The Department of Pharmacology supports an association of post-doctoral fellows and trainees interested in meeting on a regular basis. The association is coordinated by Dr. Kevin Livingston, a post-doctoral fellow in the department. One purpose of the association is to foster continual interaction and exchange of ideas among post-docs. During post-doctoral association meetings, the post-docs get together to discuss ongoing research and career development, as well as social interests.
Since the foundation of the association in 1996, our goal has been to focus on career development issues. Periodically, guest speakers are invited to our meetings to discuss different aspects concerning academic and non-academic career development. For example, Dr. Mark Dell’Acqua, Professor and Vice Chairman in the Department of Pharmacology recently spoke at one of our association meetings about his experience moving from a post-doctoral position to an academic faculty position. Our association also focuses on other career development aspects such as writing grants and preparing CVs and resumes.
The organization also established an event at the yearly departmental retreat in which former students, who received their Ph.D.s from the Pharmacology Department and have taken different career paths, come to share their experiences.
Postdoctoral Fellowships in Alcohol and Drug Abuse Research at the University of Colorado
Postdoctoral fellowships are available to support research training in the areas of alcohol and drug abuse, utilizing pharmacogenetic, molecular biological, genomic, proteomic and behavioral genetic
strategies. This NIAAA-supported multidisciplinary postdoctoral training program, originally awarded in 1976, supports eight postdoctoral fellows per year. Laboratories contributing to this training program conduct research in areas including investigations of molecular mechanisms of alcohol and drug effects in animals and cellular systems; genetic, genomic and proteomic analyses of the basis for alcohol and drug abuse in animals and humans; behavioral studies in animals; and human epidemiological studies. University of Colorado faculty preceptors in this program are at the Anschutz Medical Campus, in the Departments of Pharmacology, Psychiatry, and Medicine in the School of Medicine, and in the School of Pharmacy, as well as in the Department of Psychology and Integrative Physiology and the Institute for Behavioral Genetics in Boulder, CO.
- Must have a Ph.D. and/or M.D. degree
- Must be a US citizen or permanent resident
Preference will be given to candidates early in their postdoctoral training.
Current NIH postdoctoral stipend levels
Postdoctoral Years of Experience
7 or more
Health and dental insurance coverage is provided.
In addition, support is provided to attend one meeting annually.
Primary focus is on conducting research related to alcohol and drug abuse.
Some of the Responsibilities include:
Attend Ethics in Research and other appropriate courses
Attend and present seminars
Present research results at meeting(s)
Encouraged to write an individual postdoctoral fellowship (NRSA)
Executive Committee: Paula L. Hoffman (Principal Investigator), Dept. of Pharmacology, University of Colorado School of Medicine; John K. Hewitt, Institute for Behavioral Genetics, University of Colorado at Boulder; and Nancy R. Zahniser, Dept. of Pharmacology, University of Colorado School of Medicine.
|Name and Email Address
|Training Directors (Executive Committee)|
||neuropharmacology; neuroadaptation; alcohol tolerance and dependence; glutamate receptors; signal transduction; biochemical/genetic markers of alcohol abuse/dependence|
||neuropharmacology; drug and alcohol abuse; dopamine transporter; cocaine sensitization; ethanol and NMDA receptors; neurotransmitter release|
||behavior genetics; twins; family studies; adolescence; substance abuse; development; quantitative trait loci|
|Training Preceptors |
||alcoholism; liver transplantation; brain imaging and alcohol; HPA axis and alcohol; treatment adherence; fatty acid ethyl esters and alcohol; cocaine abuse treatment; central pontine myelinolysis treatment; hepatitis C and alcohol|
||substance dependence; human genetics; functional magnetic resonance imaging; adolescent; conduct disorder; antisocial personality disorder; child abuse and neglect; risk-taking; impulsivity|
||signal transduction; phosphorylation; protein kinases; protein phosphatases; cAMP; calcium signaling; scaffold proteins in assembly of localized signaling complexes; glutamatergic synapses; postsynaptic density; NMDA and AMPA receptor localization and trafficking|
||molecular genetics, genomics, and bioinformatics; behavior genetics; alcohol, tobacco, and substance abuse |
||neurodegeneration, apoptosis, autophagy, neurotrophic factors, signal transduction, insulin-like growth factors, dopamine neurons, cerebellar neurons |
||behavior genetics; adolescent substance abuse|
||bioinformatics; computational biology; computational pharmacology; natural language processing; gene expression arrays; knowledge-based systems|
||gene, pharmacogenomics, craving, substance abuse, fmri, addiction |
||genetics; QTLs; anesthesia; mice; gene mapping; bioinformatics; microarrays; congenics|
||alcohol; protein structure; protein-alcohol complexes; NMR spectroscopy; x-ray crystallography|
||nicotine; nicotinic receptor; schizophrenia; mental illness; nicotine addiction; molecular neurobiology; microarray|
|Dennis Petersen, PhD
||molecular mechanisms of ethanol-induced liver injury; lipid peroxidation; proteomics|
|Richard Radcliffe, PhD
||behavioral genetics; alcoholism; microarrays; mouse; alcohol tolerance; zebrafish; mutagenesis|
|Paula Riggs, MD
||comorbid disorders; adolescents; substance use disorders; integrated treatment of comorbid psychiatric disorders and substance use disorders|
|James Sikela, PhD
||genomics; disease gene identification; human gene; genome evolution|
|Andrew Smolen, PhD
||human behavioral genetics; drug abuse; alcohol abuse; attention deficit hyperactivity disorder; candidate genes; DNA polymorphisms|
|Michael Stallings, PhD
||substance use disorders; developmental psychopathology; quantitative genetics; QTL mapping; family studies|
|Boris Tabakoff, PhD
||neuroscience; molecular biology; intracellular signalling; alcohol abuse; tolerance; humans/animals/cells; dependence; drug abuse; transgenics; genetics|
|Vasilis Vasiliou, PhD
||ethanol/acetaldehyde metabolism; aldehyde dehydrogenases; oxidative stress; pharmacogenetics|
|Jeanne Wehner, PhD
||genetics; ethanol/nicotine interactions; learning and memory|
|W. Michael Zawada, PhD
||alcohol; apoptosis; brain repair; differentiation; dopamine; neurodegeneration; neuroprotection; neurotransplantation; Parkinson's disease; stem cells|
Initial inquiries should be sent to
Applicants will be asked to submit a letter of interest, CV and the names of 3 references.